Boston, MA -- (SBWIRE) -- 10/14/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: GDF Suez SA (ADR)(OTCMKTS:GDFZY), Valero Energy Corporation(NYSE:VLO), AK Steel Holding Corporation(NYSE:AKS), Cytokinetics, Inc.(NASDAQ:CYTK).
GDF Suez SA (ADR)(OTCMKTS:GDFZY) opened its shares at the price of $26.02 for the day. Its closing price was $25.95 after losing -1.70% for the day. The company traded with the total volume of 699,603 shares, while its average trading volume remained 61,673 shares. The beta of GDFZY stands at 1.15.
GDF SUEZ S.A. primarily purchases, produces, and markets natural gas and electricity in France and internationally. It is also involved in the transmission, storage, distribution, management, and development of gas infrastructures; and provision of energy and environmental services
Has GDFZY Found The Bottom and Ready To Move Up? Find Out Here
Valero Energy Corporation(NYSE:VLO) percentage change surged +2.73% to close at $36.54 with the total traded volume of 14.93 million shares, and average volume of 6.26 million. The 52 week range of the stock remained $27.89 - $48.97, while its day lowest price was $35.65 and it hit its day highest price at $37.19.
Valero Energy Corporation operates as an independent petroleum refining and marketing company. The company operates through three segments: Refining, Ethanol, and Retail.
For How Long VLO Gloss will Attract Investors? Find out via this report
AK Steel Holding Corporation(NYSE:AKS) started its trading session with the price of $3.92 and closed at $4.13 by scoring +5.09%. AKS stocks traded with total volume of 4.03 million shares, while the average trading volume remained 5.86 million shares. The beta of AKS stands at 2.52. Day range of the stock was $3.90 -$4.16.
AK Steel Holding Corporation produces flat-rolled carbon, stainless and electrical steel, and tubular products in the United States and internationally. The company produces flat-rolled carbon steels, including coated, cold-rolled, and hot-rolled carbon steel products; and specialty stainless and electrical steels in sheet and strip forms
Will AKS Continue To Move Higher? Find Out Here
Cytokinetics, Inc.(NASDAQ:CYTK) ended its day with the gain of +11.57% and closed at the price of $7.04 after opening at $6.55. Stock traded during its last trading session with the total volume of 1.77 million shares, as compared to its average volume of 745,077 shares.
Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Its lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil, is in Phase II clinical development for the potential treatment of heart failure.
Why Should Investors Buy CYTK After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)